Uncategorized

Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management

by Business Wire • 2021/06/29 • 0 Comments

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management

← Enspryng (Satralizumab) von Chugai, von der Europäischen Kommission als erste subkutane Behandlung für zu Hause bei Neuromyelitis-optica-Spektrum-Erkrankungen (NMOSD) zugelassen

Deep 6 AI Announces Substantial Expansion of its Innovative AI-Based Clinical Trial Acceleration Software and Research Ecosystem →